<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03646695</url>
  </required_header>
  <id_info>
    <org_study_id>ILM flap</org_study_id>
    <nct_id>NCT03646695</nct_id>
  </id_info>
  <brief_title>ILM Flap Transposition Versus ILM Peeling for Macular Holes: a Pilot Study</brief_title>
  <official_title>ILM Flap Transposition Versus ILM Peeling for Macular Holes: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vienna Institute for Research in Ocular Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vienna Institute for Research in Ocular Surgery</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with macular hole &lt;400µm will be randomized for ILM flap Transposition and ILM
      Peeling for surgical repair of macular holes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with macular hole with a diameter larger than 400µm have better sucess with ILM flap
      transposition, but there are no data published examining the outcome of macular hole with a
      diameter &lt;400µm. Therefore, patients with macular hole with a diameter &lt;400µm will be
      randomized for ILM flap transposition and ILM peeling for surgical repair of macular holes
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>closure of the macular hole</measure>
    <time_frame>3 months</time_frame>
    <description>closure of the macular hole will be assessed</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Macular Holes</condition>
  <arm_group>
    <arm_group_label>ILM flap</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>vitrectomy with ILM flap transposition and gas-tamponade will be performed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ILM peeling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>vitrectomy with ILM peeling and gas-tamponade will be performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ILM flap transposition</intervention_name>
    <description>during ILM flap Transposition, an ILM flap is placed on the macular hole</description>
    <arm_group_label>ILM flap</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ILM peeling</intervention_name>
    <description>during ILM Peeling the ILM is removed around the macular hole</description>
    <arm_group_label>ILM peeling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  macular hole with a diameter &lt;400µm

        Exclusion Criteria:

          -  Prior ILM peeling
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oliver Findl, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of Department of Ophthalmology, Professor, Principal Investigator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oliver Findl, Professor</last_name>
    <phone>+43 1 91021-84611</phone>
    <email>hkh.augen.abt@wgkk.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital</name>
      <address>
        <city>Vienna</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Findl, MD, MBA</last_name>
      <phone>+43 1 91021 84611</phone>
      <email>oliver@findl.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>August 23, 2018</study_first_submitted>
  <study_first_submitted_qc>August 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2018</study_first_posted>
  <last_update_submitted>October 21, 2019</last_update_submitted>
  <last_update_submitted_qc>October 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vienna Institute for Research in Ocular Surgery</investigator_affiliation>
    <investigator_full_name>Prim. Prof. Dr. Oliver Findl, MBA</investigator_full_name>
    <investigator_title>Head of Department of Ophthalmology, Professor, Principal Investigator, MBA</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

